Kymera Therapeutics

KYMR

106.1603.53% ( -3.890 )

Closed: Jul 28, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Kymera Therapeutics(KYMR) predict that the Revenue is 34.37 M (+55.5%), Beat estimate;the EBIT is -84.15 M (-13.07%), Beat estimate;the EPS is -0.71 (+13.41%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.03B55.50%

0.01B62.76%

+0.03B118.26%

EBITExceed expectations

-0.08B13.07%

-0.10B28.04%

+0.01B14.97%

EPSExceed expectations

-0.7113.41%

-0.906810.59%

+0.196824.00%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD